| 摘要 |
The invention relates to bacterial mutants, particularly from Streptococcus agalactiae, of CpsC that produce low molecular weight capsular polysaccharides. The polysaccharides are useful for producing vaccines comprising the polysaccharides alone or conjugated to proteins. |
